DCGI

AstraZeneca’s Dapagliflozin gets extended indication approval from DCGI to treat heart failure in adults

Read more

Dupixent (dupilumab) gets DCGI approval to treat moderate-to-severe atopic dermatitis

Read more

Akums gets DCGI approval for Perampanel Oral Suspension

Read more

DCGI gives EUA for mRNA-based Omicron-specific booster vaccine from Gennova

Read more

Stempeutics concludes patient enrollment for Phase 3 cell therapy trial for diabetic foot ulcer

Read more

Navigating the regulatory landscape for nutraceutical startups in India

Read more

Indian Immunologicals gets regulatory approval for measles-rubella (MR) vaccine

Read more

Eli Lilly launches Copellor in India to treat moderate-to-severe plaque psoriasis

Read more

Dr Rajeev Raghuvanshi appointed as new DCGI

Read more

Akums gets DCGI approval to launch Lobeglitazone for diabetes treatment in India

Read more